This is in line with previous results showing that MLL tumours induce tumour‐promoting TINT changes in the benign parts of the prostate, for example increased blood supply, increased lymphangiogenesis, and an M2‐dominated inflammation, that facilitate subsequent growth and spread of the MLL tumour [3, 4, 7, 8, 10]. Here, KMT2A is linked to neoplasm.